Biochemical and crystallographic characterization of a Rho effector domain of the protein serine/threonine kinase N in a complex with RhoA

Journal of Structural Biology

Volumn 126, Issue 2, 1999, Pages 166-170

  Maesaki, Ryoko ^a   Shimizu, Toshiyuki ^a   Ihara, Kentaro ^a   Kuroda, Shinya ^a,b   Kaibuchi, Kozo ^a   Hakoshima, Toshio ^a  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE N; RHO FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENZYME PURIFICATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; STOICHIOMETRY;

EID: 0033563754     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsbi.1999.4114     Document Type: Article

References (24)

1. Amano M., Mukai H., Ono Y., Chihara K., Matsui T., Hamajima Y., Okawa K., Iwamatsu A., Kaibuchi K. Identification of a putative target for Rho as the serine-threonine kinase protein kinase N. Science. 271:1996;648-650.
2. Cudney B., Patel S., Weisgraber K., Newhouse Y., McPherson A. Screening and optimization of strategies for macromolecular crystal growth. Acta Crystallogr. D50:1994;414-423.
3. Fujisawa K., Madaule P., Ishizaki T., Watanabe G., Bito H., Saito Y., Hall A., Narumiya S. Different regions of Rho determine Rho-selective binding of different classes of Rho target molecules. J. Biol. Chem. 273:1998;18943-18949.
4. Ihara K., Muraguchi S., Kato M., Shimizu T., Shirakawa M., Kuroda S., Kaibuchi K., Hakoshima T. Crystal structure of human RhoA in a dominantly active form complexed with a GTP analog. J. Biol. Chem. 273:1998;9656-9666.
5. Huang L., Hofer F., Martin G. S., Kim S.-H. Structural basis for the interaction of Ras with RalGDS. Nat. Struct. Biol. 5:1998;422-426.
6. Jancarik J., Kim S.-H. Sparse matrix sampling: A screening method for crystallization of protein. J. Appl. Crystallogr. 24:1991;409-411.
7. Kaibuchi K., Kuroda S., Amano M. Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu. Rev. Biochem. 68:1999.
8. Kawamata T., Taniguchi T., Mukai H., Kitagawa M., Hashimoto T., Maeda K., Ono Y., Tanaka C. A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein. J. Neurosci. 18:1998;7402-7410.
9. Kitagawa M., Mukai H., Shibata H., Ono Y. Purification and characterization of a fatty acid-activated protein kinase (PKN) from rat testis. Biochem. J. 310:1995;657-664.
10. Matsuzawa K., Kosako H., Inagaki N., Shibata H., Mukai H., Ono Y., Amano M., Kaibuchi K., Matsuura Y., Azuma I., Inagaki M. Domain-specific phosphorylation of vimentin and glial fibrillary acidic protein by PKN. Biochem. Biophys. Res. Commun. 234:1997;621-625.
11. Matthews B. W. Solvent content of protein crystals. J. Mol. Biol. 33:1968;491-497.
12. Milburn M. V., Tong L., de Vos A. M., Brunger A., Yamaizumi Z., Nishimura S., Kim S.-H. Molecular switch for signal transduction: Structural differences between active and inactive forms of proto-oncogenic ras proteins. Science. 247:1990;939-945.
13. Mukai H., Ono Y. A novel protein kinase with leucine zipper-like sequences: Its catalytic domain is highly homologous to that of protein kinase C. Biochem. Biophys. Res. Commun. 199:1994;897-904.
14. Mukai H., Kitagawa M., Shibata H., Takanaga H., Mori K., Shimakawa M., Miyahara M., Hirao K., Ono Y. Activation of PKN, a novel 120-KDa protein kinase with leucine zipper-like sequences, by unsaturated fatty acids and by limited proteolysis. Biochem. Biophys. Res. Commun. 204:1994;348-356.
15. Mukai H., Toshimori M., Shibata H., Kitagawa M., Shimakawa M., Miyahara M., Sunakawa H., Ono Y. PKN associates and phosphorylates the head-rod domain of neurofilament protein. J. Biol. Chem. 271:1996;9816-9822.
16. Mukai H., Toshimori M., Shibata H., Takanaga H., Kitagawa M., Miyahara M., Shimakawa M., Ono Y. Interaction of PKN with α-actinin. J. Biol. Chem. 272:1997;4740-4746.
17. Nassar N., Horn G., Herrmann C., Scherer A., McCormick F., Wittinghofer A. The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature. 375:1995;554-560.
18. Navaza J. AMoRe: An automated package for molecular replacement. Acta Crystallogr. A50:1994;157-163.
19. Ostermeier C., Brunger A. Structural basis of Rab effector specificity: Crystal structure of the small G protein Rab3A complexed with the effector domain of rabphilin-3A. Cell. 96:1999;363-374.
20. Otwinowski Z., Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:1997;307-326.
21. Shibata H., Mukai H., Inagaki Y., Homma Y., Kimura K., Kaibuchi K., Narumiya S., Ono Y. Characterization of the interaction between RhoA and the amino-terminal region of PKN. FEBS Lett. 385:1996;221-224.
22. Takahashi M., Mukai H., Toshimori M., Miyamoto M., Ono Y. Proteolytic activation of PKN by caspase-3 or related protease during apoptosis. Proc. Natl. Acad. Sci. USA. 95:1998;11566-11571.
23. Takanaga H., Mukai H., Shibata H., Toshimori M., Ono Y. PKN interacts with a paraneoplastic cerebellar degeneration-associated antigen, which is a potential transcription factor. Exp. Cell Res. 241:1998;363-372.
24. Watanabe G., Saito Y., Madaule P., Ishizaki T., Fujisawa K., Morii N., Mukai H., Ono Y., Kakizuka A., Narumiya S. Protein kinase N (PKN) and PKN-related protein rhophilin as targets of small GTPase Rho. Science. 271:1996;645-648.